Form D — Spine BioPharma, Inc.
0001852647-26-000002 · filed Jun 5, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Reported offering amount
- $8,500,000
- Reported amount sold
- $384,798
- Minimum investment
- $0
- Investors
- 3
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Spine BioPharma, Inc.
- CIK
- 1852647
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 505 PARK AVENUE, 14TH FLOOR
NEW YORK, NY 10022 - Phone
- 212-583-9700
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Marc R. Viscogliosi · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Fran Magee · Executive OfficerNew York, NY Find on LinkedIn ↗
-
Thomas Bumol, PhD · DirectorNew York, NY Find on LinkedIn ↗
-
Frank Cammisa, MD · DirectorNew York, NY Find on LinkedIn ↗
-
John J. Viscogliosi · DirectorNew York, NY Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗